1
|
Neto ABL, Vasconcelos NBR, Dos Santos TR, Duarte LEC, Assunção ML, de Sales-Marques C, Ferreira HDS. Prevalence of IGFBP3, NOS3 and TCF7L2 polymorphisms and their association with hypertension: a population-based study with Brazilian women of African descent. BMC Res Notes 2021; 14:186. [PMID: 34001234 PMCID: PMC8130172 DOI: 10.1186/s13104-021-05598-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/16/2021] [Accepted: 05/05/2021] [Indexed: 11/10/2022] Open
Abstract
Objective African ancestry seems to be a risk factor for hypertension; however, few genetic studies have addressed this issue. This study aimed to investigate the prevalence of polymorphisms NOS3; rs1799983, IGFBP3; rs11977526 and TCF7L2; rs7903146 in Brazilian women of African descent and their association with hypertension. Results The prevalences of the less frequent genotypes were 26.5% TT genotype of NOS3; rs1799983, 16.7% AA genotype of IGFBP3; rs11977526, and 18.3% TT genotype of TCF7L2; rs7903146. For these conditions, the prevalence of hypertension and PR (adjusted) relatively to the ancestral genotype were, respectively: 52.0% vs 24.5% (PR = 1.54; p < 0.001), 62.0% vs 24.1% (PR = 1.59; p < 0.001), and 38.9% vs 27.9% (PR = 0.86; p = 0.166). Associations with hypertension were statistically significant, except for the TCF7L2; rs7903146 polymorphism, after adjusted analysis. Brazilian Afro-descendant women with the TT genotype for the NOS3 gene and the AA genotype for the IGFBP3 gene are more susceptible to hypertension. The understanding of underlying mechanisms involving the pathogenesis of hypertension can motivate research for the development of new therapeutic targets related to nitric oxide metabolism and the management of oxidative stress. Supplementary Information The online version contains supplementary material available at 10.1186/s13104-021-05598-5.
Collapse
Affiliation(s)
- Abel Barbosa Lira Neto
- Federal University of Alagoas, Institute of Biological and Health Sciences, Postgraduate Program in Health Sciences, Campus A.C. Simões, Highway BR 104 North, Tabuleiro Do Martins, Maceió, Alagoas, 57072-970, Brazil. .,, Rua Costa Gama, 1160, Caçimbas, Arapiraca, Alagoas, 57038-430, Brazil.
| | - Nancy Borges Rodrigues Vasconcelos
- Federal University of Alagoas, Institute of Biological and Health Sciences, Postgraduate Program in Health Sciences, Campus A.C. Simões, Highway BR 104 North, Tabuleiro Do Martins, Maceió, Alagoas, 57072-970, Brazil
| | - Tamara Rodrigues Dos Santos
- Federal University of Alagoas, Institute of Biological and Health Sciences, Postgraduate Program in Health Sciences, Campus A.C. Simões, Highway BR 104 North, Tabuleiro Do Martins, Maceió, Alagoas, 57072-970, Brazil
| | - Luisa Elvira Cavazzani Duarte
- Federal University of Alagoas, Institute of Biological and Health Sciences, Postgraduate Program in Health Sciences, Campus A.C. Simões, Highway BR 104 North, Tabuleiro Do Martins, Maceió, Alagoas, 57072-970, Brazil
| | - Monica Lopes Assunção
- Federal University of Alagoas, Institute of Biological and Health Sciences, Postgraduate Program in Health Sciences, Campus A.C. Simões, Highway BR 104 North, Tabuleiro Do Martins, Maceió, Alagoas, 57072-970, Brazil
| | - Carolinne de Sales-Marques
- Federal University of Alagoas, Institute of Biological and Health Sciences, Postgraduate Program in Health Sciences, Campus A.C. Simões, Highway BR 104 North, Tabuleiro Do Martins, Maceió, Alagoas, 57072-970, Brazil
| | - Haroldo da Silva Ferreira
- Federal University of Alagoas, Institute of Biological and Health Sciences, Postgraduate Program in Health Sciences, Campus A.C. Simões, Highway BR 104 North, Tabuleiro Do Martins, Maceió, Alagoas, 57072-970, Brazil
| |
Collapse
|
2
|
Welters A, Klüppel C, Mrugala J, Wörmeyer L, Meissner T, Mayatepek E, Heiss C, Eberhard D, Lammert E. NMDAR antagonists for the treatment of diabetes mellitus-Current status and future directions. Diabetes Obes Metab 2017; 19 Suppl 1:95-106. [PMID: 28880473 DOI: 10.1111/dom.13017] [Citation(s) in RCA: 20] [Impact Index Per Article: 2.9] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 04/03/2017] [Revised: 05/18/2017] [Accepted: 05/20/2017] [Indexed: 12/16/2022]
Abstract
Diabetes mellitus is characterized by chronically elevated blood glucose levels accelerated by a progressive decline of insulin-producing β-cells in the pancreatic islets. Although medications are available to transiently adjust blood glucose to normal levels, the effects of current drugs are limited when it comes to preservation of a critical mass of functional β-cells to sustainably maintain normoglycemia. In this review, we recapitulate recent evidence on the role of pancreatic N-methyl-D-aspartate receptors (NMDARs) in β-cell physiology, and summarize effects of morphinan-based NMDAR antagonists that are beneficial for insulin secretion, glucose tolerance and islet cell survival. We further discuss NMDAR-mediated molecular pathways relevant for neuronal cell survival, which may also be important for the preservation of β-cell function and mass. Finally, we summarize the literature for evidence on the role of NMDARs in the development of diabetic long-term complications, and highlight beneficial pharmacologic aspects of NMDAR antagonists in diabetic nephropathy, retinopathy as well as neuropathy.
Collapse
Affiliation(s)
- Alena Welters
- Institute of Metabolic Physiology, Department of Biology, Heinrich Heine University, Düsseldorf, Germany
- Department of General Pediatrics, Neonatology and Pediatric Cardiology, University Children's Hospital Düsseldorf, Medical Faculty, Heinrich Heine University, Düsseldorf, Germany
| | - Carina Klüppel
- Institute of Metabolic Physiology, Department of Biology, Heinrich Heine University, Düsseldorf, Germany
| | - Jessica Mrugala
- Institute for Beta Cell Biology, German Diabetes Center, Leibniz Center for Diabetes Research, Düsseldorf, Germany
- German Center for Diabetes Research, Helmholtz Zentrum München, Neuherberg, Düsseldorf, Germany
| | - Laura Wörmeyer
- Institute of Metabolic Physiology, Department of Biology, Heinrich Heine University, Düsseldorf, Germany
- Department of General Pediatrics, Neonatology and Pediatric Cardiology, University Children's Hospital Düsseldorf, Medical Faculty, Heinrich Heine University, Düsseldorf, Germany
| | - Thomas Meissner
- Department of General Pediatrics, Neonatology and Pediatric Cardiology, University Children's Hospital Düsseldorf, Medical Faculty, Heinrich Heine University, Düsseldorf, Germany
| | - Ertan Mayatepek
- Department of General Pediatrics, Neonatology and Pediatric Cardiology, University Children's Hospital Düsseldorf, Medical Faculty, Heinrich Heine University, Düsseldorf, Germany
| | - Christian Heiss
- Division of Cardiology, Pulmonology, and Vascular Medicine, Medical Faculty, Heinrich Heine University, Düsseldorf, Germany
| | - Daniel Eberhard
- Institute of Metabolic Physiology, Department of Biology, Heinrich Heine University, Düsseldorf, Germany
| | - Eckhard Lammert
- Institute of Metabolic Physiology, Department of Biology, Heinrich Heine University, Düsseldorf, Germany
- Institute for Beta Cell Biology, German Diabetes Center, Leibniz Center for Diabetes Research, Düsseldorf, Germany
- German Center for Diabetes Research, Helmholtz Zentrum München, Neuherberg, Düsseldorf, Germany
| |
Collapse
|
3
|
Kim YC, Yun KH, Woo SH, Jeong YH, Lim JH, Hwang KB, Jeong JW, Lee MR, Lee JM, Rhee SJ, Kim NH, Oh SK, Jeong JW. Diurnal variation of flow-mediated dilatation in healthy humans. Clin Hypertens 2015; 21:6. [PMID: 26893919 PMCID: PMC4750800 DOI: 10.1186/s40885-015-0019-4] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/26/2014] [Revised: 12/26/2014] [Accepted: 03/02/2015] [Indexed: 01/22/2023] Open
Abstract
Introduction The measurement of flow-mediated dilatation (FMD) via ultrasound has been established as a reliable non-invasive measurement of endothelial function. However, the guidelines mention nothing regarding diurnal variation of FMD. Thus, we investigated the FMD in healthy people and diurnal variation of FMD. Methods Twenty-five apparently healthy persons participated in this study. All participants had no history of cardiovascular diseases, hypertension, or diabetes and used any medication. For each volunteer, the measurements were repeated in the morning and afternoon on two different days. We checked capillary blood glucose, total cholesterol, triglyceride, high-density lipoprotein (HDL), and low-density lipoprotein (LDL)-cholesterol. Results The average of FMD measurements was 8.45% ± 2.39%. The mean values of systolic and diastolic blood pressure, heart rate, lipid profiles, and glucose levels were similar between the morning and afternoon measurements after 9-h fasting. There was no significant difference of FMD measurements between the morning and afternoon (8.32% ± 2.27% and 8.58% ± 2.56%, p = 0.329). Moreover, there was significant correlation between FMD in the morning and afternoon (r = 0.856, p < 0.001). Conclusions Our study shows measurement of FMD was 8.45% in healthy Koreans. Also, there was no significant difference of FMD measurements between the morning and afternoon.
Collapse
Affiliation(s)
- Yong Cheol Kim
- Departments of Cardiovascular Medicine, Wonkwang University School of Medicine and Hospital, 895 Muwang-ro, Iksan, Jeonbuk 570-711 Korea
| | - Kyeong Ho Yun
- Departments of Cardiovascular Medicine, Wonkwang University School of Medicine and Hospital, 895 Muwang-ro, Iksan, Jeonbuk 570-711 Korea ; Regional Cardiocerebrovascular Center, Wonkwang University School of Medicine and Hospital, 895 Muwang-ro, Iksan, Jeonbuk 570-711 Korea
| | - Sun Ho Woo
- Departments of Cardiovascular Medicine, Wonkwang University School of Medicine and Hospital, 895 Muwang-ro, Iksan, Jeonbuk 570-711 Korea
| | - Young Hoon Jeong
- Departments of Cardiovascular Medicine, Wonkwang University School of Medicine and Hospital, 895 Muwang-ro, Iksan, Jeonbuk 570-711 Korea
| | - Jae Hong Lim
- Departments of Cardiovascular Medicine, Wonkwang University School of Medicine and Hospital, 895 Muwang-ro, Iksan, Jeonbuk 570-711 Korea
| | - Kyo Bum Hwang
- Departments of Cardiovascular Medicine, Wonkwang University School of Medicine and Hospital, 895 Muwang-ro, Iksan, Jeonbuk 570-711 Korea
| | - Jin Woo Jeong
- Departments of Cardiovascular Medicine, Wonkwang University School of Medicine and Hospital, 895 Muwang-ro, Iksan, Jeonbuk 570-711 Korea
| | - Mi Rim Lee
- Regional Cardiocerebrovascular Center, Wonkwang University School of Medicine and Hospital, 895 Muwang-ro, Iksan, Jeonbuk 570-711 Korea
| | - Jeong Mi Lee
- Department of Public Health, Wonkwang University Graduate School, Iksan, Korea
| | - Sang Jae Rhee
- Departments of Cardiovascular Medicine, Wonkwang University School of Medicine and Hospital, 895 Muwang-ro, Iksan, Jeonbuk 570-711 Korea ; Regional Cardiocerebrovascular Center, Wonkwang University School of Medicine and Hospital, 895 Muwang-ro, Iksan, Jeonbuk 570-711 Korea
| | - Nam-Ho Kim
- Departments of Cardiovascular Medicine, Wonkwang University School of Medicine and Hospital, 895 Muwang-ro, Iksan, Jeonbuk 570-711 Korea ; Regional Cardiocerebrovascular Center, Wonkwang University School of Medicine and Hospital, 895 Muwang-ro, Iksan, Jeonbuk 570-711 Korea
| | - Seok Kyu Oh
- Departments of Cardiovascular Medicine, Wonkwang University School of Medicine and Hospital, 895 Muwang-ro, Iksan, Jeonbuk 570-711 Korea ; Regional Cardiocerebrovascular Center, Wonkwang University School of Medicine and Hospital, 895 Muwang-ro, Iksan, Jeonbuk 570-711 Korea
| | - Jin-Won Jeong
- Departments of Cardiovascular Medicine, Wonkwang University School of Medicine and Hospital, 895 Muwang-ro, Iksan, Jeonbuk 570-711 Korea ; Regional Cardiocerebrovascular Center, Wonkwang University School of Medicine and Hospital, 895 Muwang-ro, Iksan, Jeonbuk 570-711 Korea
| |
Collapse
|
4
|
Usefulness of brachial artery flow-mediated dilation to predict long-term cardiovascular events in subjects without heart disease. Am J Cardiol 2014; 113:162-7. [PMID: 24169007 DOI: 10.1016/j.amjcard.2013.08.051] [Citation(s) in RCA: 116] [Impact Index Per Article: 11.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 08/03/2013] [Revised: 08/26/2013] [Accepted: 08/26/2013] [Indexed: 01/07/2023]
Abstract
Endothelial dysfunction is considered an important prognostic factor in atherosclerosis. To determine the long-term association of brachial artery flow-mediated dilation (FMD) and adverse cardiovascular (CV) events in healthy subjects, we prospectively assessed brachial FMD in 618 consecutive healthy subjects with no apparent heart disease, 387 men (63%), and mean age 54 ± 11 years. After overnight fasting and discontinuation of all medications for ≥12 hours, FMD was assessed using high-resolution linear array ultrasound. Subjects were divided into 2 groups: FMD ≤11.3% (n = 309) and >11.3% (n = 309), where 11.3% is the median FMD, and were comparable regarding CV risk factors, lipoproteins, fasting glucose, C-reactive protein, concomitant medications, and Framingham 10-year risk score. In a mean clinical follow-up of 4.6 ± 1.8 years, the composite CV events (all-cause mortality, nonfatal myocardial infarction, hospitalization for heart failure or angina pectoris, stroke, coronary artery bypass grafting, and percutaneous coronary interventions) were significantly more common in subjects with FMD ≤11.3% rather than >11.3% (15.2% vs 1.2%, p = 0.0001, respectively). Univariate analysis demonstrated that the median FMD significantly predicted CV events (odds ratio 2.78, 95% CI 1.35 to 5.71, p <0.001). Multivariate analysis, controlling for traditional CV risk factors, demonstrated that median FMD was the best independent predictor of long-term CV adverse events (odds ratio 2.93, 95% CI 1.28 to 6.68, p <0.001). In conclusion, brachial artery median FMD independently predicts long-term adverse CV events in healthy subjects with no apparent heart disease in addition to those derived from traditional risk factor assessment.
Collapse
|
5
|
Beigel R, Dvir D, Arbel Y, Shechter A, Feinberg MS, Shechter M. Pulse pressure is a predictor of vascular endothelial function in middle-aged subjects with no apparent heart disease. Vasc Med 2010; 15:299-305. [PMID: 20724375 DOI: 10.1177/1358863x10373300] [Citation(s) in RCA: 20] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Elevated pulse pressure (PP) is increasingly being recognized as a cardiovascular risk factor. To investigate whether PP is associated with endothelial function in subjects with no apparent heart disease we prospectively assessed brachial flow-mediated dilation (FMD) in 525 consecutive subjects with no apparent heart disease [323 (61%) men, mean age 52 +/- 11 years, mean body mass index (BMI) 26 +/- 4 kg/m(2)]. Following an overnight fast and discontinuation of all medications for >/= 12 hours, the FMD and endothelium-independent, nitroglycerin-mediated vasodilation (NTG) were assessed using high-resolution linear array ultrasound. Univariate linear analysis revealed a significant inverse association between FMD and PP (r = -0.65, p < 0.01), systolic blood pressure (r = -0.52, p < 0.01) and age (r = -0.21, p < 0.05). Multivariate analysis showed that PP was the strongest independent predictor of FMD. We therefore divided the study population into two groups: group A (n = 290) </= the median PP, and group B (n = 235) > the median PP of 50 mmHg. Male sex, hypertension, diabetes, BMI, heart rate, and the use of aspirin, long-acting nitrates, calcium channel blockers, angiotensin-converting enzyme inhibitors and beta blockers were significantly more common in Group B compared with Group A. FMD but not NTG was significantly greater in patients with PP </= the median PP, compared with > the median PP (14.9 +/- 7.9% vs 10.8 +/- 8.8%, p < 0.001 and 16.1 +/- 9.6% vs 14.8 +/- 8.4%, p = 0.38; respectively). Thus, PP is inversely associated with brachial FMD in middle-aged subjects with no apparent heart disease, suggesting a potential mechanism whereby elevated PP contributes to cardiovascular disease. Long-term follow-up is warranted to elucidate the incidence of coronary artery disease in both study groups.
Collapse
Affiliation(s)
- Roy Beigel
- Leviev Heart Center, Chaim Sheba Medical Center, Tel Hashomer, Israel, Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel
| | | | | | | | | | | |
Collapse
|
6
|
Shechter M, Issachar A, Marai I, Koren-Morag N, Freinark D, Shahar Y, Shechter A, Feinberg MS. Long-term association of brachial artery flow-mediated vasodilation and cardiovascular events in middle-aged subjects with no apparent heart disease. Int J Cardiol 2008; 134:52-8. [PMID: 18479768 DOI: 10.1016/j.ijcard.2008.01.021] [Citation(s) in RCA: 162] [Impact Index Per Article: 10.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/31/2007] [Revised: 12/20/2007] [Accepted: 01/11/2008] [Indexed: 10/22/2022]
Abstract
BACKGROUND Endothelial dysfunction is considered an important prognostic factor in atherosclerosis. The aim of this study was to detect the long-term association of peripheral vascular endothelial function and clinical outcome in healthy subjects without apparent coronary artery disease (CAD). METHODS We prospectively assessed brachial flow-mediated dilation (FMD) in 435 consecutive healthy subjects: 281 (65%) men, mean age 54+/-12 years and body mass index 28+/-4 kg/m(2). After overnight fasting and discontinuation of all medications for > or =12 h, FMD and endothelium-independent nitroglycerin-mediated vasodilation were assessed using high resolution linear array ultrasound. RESULTS Subjects were divided into 2 groups: below (n=221) and above (n=214) the median FMD of 10.7%, and were comparable regarding CAD risk factors, lipoproteins, fasting glucose, C-reactive protein, and concomitant medications, with a mean clinical follow-up of 32+/-2 months. Composite cardiovascular endpoints (all-cause mortality, non-fatal myocardial infarction, heart failure or angina pectoris hospitalization, stroke, coronary artery bypass grafting and percutaneous coronary interventions) were significantly more common in subjects with below median FMD of 10.7%, than above (11.8% vs 4.7%, p=0.007, respectively). Univariate analysis demonstrated that median FMD significantly predicted cardiovascular events [odds ratio (OR) of 2.78 and 95% CI 1.35 to 5.71 (p=0.003)]. After multivariate analysis including conventional CAD risk factors, median FMD was the best independent predictor of long-term cardiovascular adverse events [OR of 2.70 and 95% CI 1.16 to 6.32 (p=0.011)]. CONCLUSIONS Brachial artery median FMD independently predicts long-term adverse cardiovascular events in healthy subjects in addition to traditional risk factor assessment.
Collapse
Affiliation(s)
- Michael Shechter
- Heart Institute, Chaim Sheba Medical Center, Tel Hashomer, Israel; Sackler Faculty of Medicine, Tel Aviv University, Israel.
| | | | | | | | | | | | | | | |
Collapse
|
7
|
Toth J, Racz A, Kaminski PM, Wolin MS, Bagi Z, Koller A. Asymmetrical Dimethylarginine Inhibits Shear Stress–Induced Nitric Oxide Release and Dilation and Elicits Superoxide-Mediated Increase in Arteriolar Tone. Hypertension 2007; 49:563-8. [PMID: 17242303 DOI: 10.1161/01.hyp.0000256764.86208.3d] [Citation(s) in RCA: 34] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
l-arginine is the substrate used by NO synthase to produce the vasodilator NO. However, in several human diseases, such as hyperhomocysteinemia, diabetes mellitus, and hypertension, there is an increase in serum levels of methylated l-arginines, such as asymmetrical dimethylarginine (ADMA), which cannot be used by NO synthase to produce NO. Yet, the functional consequence of increased levels of ADMA on the vasomotor function of resistance vessels has not been delineated. We hypothesized that elevated levels of exogenous ADMA inhibit NO mediation of flow/shear stress-dependent dilation of isolated arterioles. In the presence of indomethacin, isolated arterioles from rat gracilis muscle (approximately 165 microm at 80 mm Hg) were incubated with ADMA (10(-4) mol/L), which eliminated the dilations to increases in intraluminal flow (control: from 164+/-5.4 to 188+/-3.8 microm versus ADMA: from 171+/-6.1 to 173+/-6.3 microm at 20 microL/min). ADMA did not affect dilations to nifedipine (10(-6) mol/L; control: 63.4+/-2%, ADMA: 65.8+/-3%) or 8-bromo cGMP (10(-4) mol/L; control: 51.2+/-2.1%, ADMA: 49.3+/-3.4%). In addition, ADMA elicited significant constriction of arterioles (from 173+/-17 microm to 138+/-16 microm at 80 mm Hg), which was prevented by previous incubation of arterioles with polyethylene-glycol (PEG) superoxide dismutase (SOD; 120 U/mL, control: 155+/-11 microm versus ADMA: 150+/-14 microm). Correspondingly, ADMA increased PEG-SOD reversible manner the production of vascular superoxide assessed by lucigenin-enhanced chemiluminescence and ethidium bromide fluorescence. Thus, increased levels of ADMA in various diseases could inhibit the regulation of arteriolar resistance by shear stress-induced release of NO and elicit superoxide-mediated increase in basal tone, both of which favor the development of hypertension.
Collapse
Affiliation(s)
- Janos Toth
- Department of Pathophysiology, Semmelweis University, Budapest, Hungary
| | | | | | | | | | | |
Collapse
|
8
|
Williamson PM, Kohlhagen JL, Mangos GJ, Whitworth JA, Kelly JJ. Acute effects of hydrocortisone on plasma nitrate/nitrite activity and forearm vasodilator responsiveness in normal human subjects. Clin Exp Pharmacol Physiol 2005; 32:162-6. [PMID: 15743397 DOI: 10.1111/j.1440-1681.2005.04173.x] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Abstract
1. The aim of the present study was to examine the acute effects of cortisol infusion on plasma nitrate/nitrite (NO) activity and forearm vascular responsiveness to acetylcholine. 2. We performed two randomized, placebo-controlled, cross-over studies. Study A examined the effects of intravenous hydrocortisone (200 mg over a 3 h period) on blood pressure (BP) and plasma NO activity in six healthy male volunteers. Study B examined the effects of intra-arterial hydrocortisone on cholinergic vasodilator responsiveness in six healthy male volunteers. Vasodilator responsiveness was measured by bilateral strain gauge plethysmography. 3. In study A, there was no significant change in BP during the hydrocortisone infusion. Comparing values obtained following 180 min infusion of hydrocortisone and control, there were significant increases in plasma cortisol (3441 +/- 342 vs 209 +/- 29 nmol/L, respectively; P < 0.001) and glucose (5.7 +/- 0.2 vs 4.6 +/- 0.2 mmol/L, respectively; P < 0.05) and a reduction in plasma renin concentration (PRC) (8.1 +/- 1.2 vs 11.0 +/- 1.8 pg/mL, respectively; P < 0.05) following hydrocortisone infusion. However, there were no significant changes in either plasma NO or in the endogenous NO synthase inhibitors asymmetrical and symmetrical dimethylarginine. 4. In study B, there was no significant change in BP or in cholinergic vasodilator responsiveness during the hydrocortisone infusion. 5. Short-term cortisol infusions do not alter biochemical or physiological markers of NO activity. If cortisol-induced hypertension is mediated by suppression of NO activity in humans, it seems likely that these changes take more than 3 h to become detectable.
Collapse
Affiliation(s)
- Paula M Williamson
- Department of Medicine and Renal Medicine, St George Hospital, University of New South Wales, Kogarah, New South Wales, Australia.
| | | | | | | | | |
Collapse
|